Phase
Condition
Allergies & Asthma
Common Cold
Allergy (Pediatric)
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Signed Consent of the patient;
Clinical diagnosis of moderate - severe persistent allergic rhinitis according to ARIAclassification(Allergic Rhinitis and Its Impact on Asthma);
Adults aged ≥ 18 years old;
Evidence of sensitization to aeroallergens in examination (immediate skin tests orserum specific IgE) in the 12 months prior to inclusion.
Exclusion
Exclusion Criteria:
Decongestants dependent patients or patients receiving allergen specificimmunotherapy;
Patients who were in use of oral antihistamines or decongestants in the past 15 days;
Patients who were treated with systemic corticosteroids in the last month;
Patients on treatment with monoamine oxidase inhibitors (MAOIs);
Patients with history of hypersensitivity to any of the formula compounds;
Patients with any clinically significant disease that in the investigator opinion cannot participate in the study
Patients who have uncontrolled asthma, chronic sinusitis, drug related rhinitis andnasal anatomic abnormalities.
Participation in clinical trial in 30 days prior to study entry;
Study Design
Connect with a study center
IMA - Instituto de Pesquisa Clínica e Medicina Avançada
São Paulo,
BrazilSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.